Revolution Medicines

About:

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

Website: https://www.revmed.com

Top Investors: Fidelity, The Column Group, Boxer Capital, Third Rock Ventures, Vivo Capital

Description:

Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex chemicals of life by reconfiguring natural substances into best-in-class medicines. REVOLUTION Medicines builds upon the vision of the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute, who invented a transformative method for synthesizing original compounds that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive license agreement with the University of Illinois to practice and expand this technology. REVOLUTION Medicines’ approach is a rapid, standardized and powerful process for assembling simple “chemical building blocks” into refined natural product-like structures. These optimized compounds have significant potential as best-in-class drug candidates.

Total Funding Amount:

$1.25B

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2015-01-01

Contact Email:

inquires(AT)revolutionmedicines.com

Founders:

Alexis Borisy, David Pompliano, Mark A. Goldsmith, Martin D. Burke

Number of Employees:

251-500

Last Funding Date:

2023-03-02

IPO Status:

Public

© 2025 bioDAO.ai